ZOLINZA (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the ZOLINZA drug offered from Merck Sharp & Dohme Corp.. This Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | vorinostat |
| SUBSTANCE NAME: | VORINOSTAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-10-06 |
| END MARKETING DATE: | 0000-00-00 |
ZOLINZA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZOLINZA from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2006-10-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-0568_87947de5-7d26-41bf-be8b-10cf3a6f28c3 |
| PRODUCT NDC: | 0006-0568 |
| APPLICATION NUMBER: | NDA021991 |
Other VORINOSTAT Pharmaceutical Manufacturers / Labelers:
